Patents by Inventor Garnet Edward Howells

Garnet Edward Howells has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10300065
    Abstract: The present disclosure relates to methods for reducing the rate of cardiovascular death, myocardial infarction, or stroke in a patient in recognized need thereof, comprising administering to the patient a pharmaceutical composition comprising 60 mg ticagrelor twice daily.
    Type: Grant
    Filed: January 27, 2016
    Date of Patent: May 28, 2019
    Assignee: ASTRAZENECA AB
    Inventors: Lars Magnus Andersson, Tomas Lars-Gunnar Andersson, Olof Fredrik Bengtsson, Hans Peter Held, Garnet Edward Howells, Eva Christina Jensen, Robert Storey
  • Publication number: 20090105484
    Abstract: A compound of the formula (VIII) wherein each X is independently H or F; and R is selected from hydrogen, halogen, cyano, methyl, cyanomethyl, fluoromethyl, difluoromethyl, trifluoromethyl and —Si[(1-4C)alkyl]3; and processes for preparing a compound of formula (VIII) by bromination of a compound of the formula (VII),
    Type: Application
    Filed: May 24, 2005
    Publication date: April 23, 2009
    Applicant: AstraZeneca
    Inventors: Janette Cherryman, Murray Watson Cuthbert, Jerome Dubiez, Garnet Edward Howells, Keith Raymond Mulholland